Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trial priorities, adaptive strategies, and equitable partnerships for the Bundibugyo Ebola outbreak.

The Lancet. Infectious diseases·2026
Same author

Ebola outbreak caused by Bundibugyo virus: challenges and priorities for epidemic preparedness and response.

Lancet (London, England)·2026
Same author

Logistical Challenges in Platform Randomized Trials - Operational Realities That Curb the Promise of Efficiency.

Clinical epidemiology·2026
Same author

The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.

Annals of internal medicine·2026
Same author

Clade-specific ophthalmic manifestations of mpox: an umbrella review and meta-analysis of systematic reviews.

The British journal of ophthalmology·2025
Same author

Retraction notice to Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial [The Lancet Regional Health-Americas Volume 6, February 2022, 100142].

Lancet regional health. Americas·2025
Same journal

Stress Disorders and Human Papillomavirus-Related Cancer Rates: A Population-Based Cohort Study in Denmark.

Clinical epidemiology·2026
Same journal

Making Statistics Clinically Meaningful.

Clinical epidemiology·2026
Same journal

Sensitivity of Administrative Coding for Heart Disease in Pregnancy.

Clinical epidemiology·2026
Same journal

Cohort Profile: The Central Denmark Cancer Cohort.

Clinical epidemiology·2026
Same journal

The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.

Clinical epidemiology·2026
Same journal

Pregnancy Outcomes in Women with Type 1 Diabetes by Socioeconomic and Mental Health Disadvantages.

Clinical epidemiology·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Multiple treatment comparison meta-analyses: a step forward into complexity.

Edward J Mills1, Nick Bansback, Isabella Ghement

  • 1Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada;

Clinical Epidemiology
|July 14, 2011
PubMed
Summary
This summary is machine-generated.

Multiple treatment comparison (MTC) meta-analysis aids comparative effectiveness research by analyzing interventions not directly tested in trials. This method offers valuable insights but requires careful consideration of its methodological challenges for optimal clinical application.

Keywords:
meta-analysismixed treatment comparisonmultiple treatment comparisonnetwork

Related Experiment Videos

Last Updated: May 31, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Medical research methodology
  • Evidence-based medicine
  • Comparative effectiveness research

Background:

  • Meta-analysis is crucial for clinical and policy decisions.
  • Multiple treatment comparison (MTC) meta-analysis is an advanced technique.
  • MTC allows comparison of interventions not directly studied together.

Purpose of the Study:

  • To explain the methodological concepts of MTC meta-analysis.
  • To highlight challenges specific to MTC applications in medicine.
  • To assess the utility and transparency of MTC for the research community.

Main Methods:

  • Discussion of methodological concepts including heterogeneity, model selection, and sample size.
  • Exploration of domain-specific challenges, such as patient baseline risks.
  • Review of existing literature and methodological principles for MTC.

Main Results:

  • MTC meta-analysis can provide comparative effectiveness inferences for indirectly compared treatments.
  • Key methodological considerations include heterogeneity, model choice, and sample size adequacy.
  • Domain-specific factors, like baseline patient risks, present unique challenges.

Conclusions:

  • MTC meta-analysis is a valuable tool for comparative effectiveness studies.
  • Further research is needed to address its complexities and enhance transparency.
  • Wider adoption by researchers and clinicians depends on demonstrated utility and clarity.